Skip to main content

FDA Approvals

FDA Approvals
Tazverik First FDA-Approved Drug for Advanced Epithelioid Sarcoma Ineligible for Resection
Read More
FDA Approvals, Pancreatic Cancer, Oncology
Lynparza Indicated for Maintenance Treatment of Metastatic Pancreatic Cancer with BRCA Mutation
Read More
FDA Approvals
Mosunetuzumab, a Dual-Targeted Antibody, Shows Complete Remissions in Relapsed/Refractory NHL After CAR T-Cell Therapy
Phoebe Starr
Phoebe Starr
Read More
FDA Approvals, In the News
Tazverik Receives FDA Approval as First Treatment Specifically for Metastatic or Locally Advanced Epithelioid Sarcoma
Read More
FDA Approvals, In the News
Mixed Findings in Annual Cancer Statistics Report
Read More
FDA Approvals, In the News
FDA Grants Approval to Avapritinib for Patients with GIST
Read More
FDA Approvals, In the News
Recap of FDA Drug Approvals in 2019
Read More
FDA Approvals, In the News
Regenerative Medicine Advanced Therapy Designation Granted to ADP-A2M4 for Synovial Sarcoma
Read More
FDA Approvals
FDA Oncology Update
Read More
FDA Approvals, In the News
November 11, 2019 — Oncology News & Updates
Read More
Page 19 of 53
Results 181 - 190 of 527